Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting DNA secondary structures.

R M Wadkins1

  • 1Laboratory of Biophysical Chemistry, Cancer Therapy & Research Center, Institute for Drug Development, 14960 Omicron Drive, San Antonio, Texas 78245, USA. rwadkins@saci.org

Current Medicinal Chemistry
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.

British journal of pharmacology·2010
Same author

Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases.

Molecular pharmacology·2001
Same author

The role of the loop in binding of an actinomycin D analog to hairpins formed by single-stranded DNA.

Archives of biochemistry and biophysics·2001
Same author

7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents.

Molecular pharmacology·2000
Same author

Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts.

Cancer research·1999
Same author

The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase.

Cancer research·1999
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
Same journal

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

Current medicinal chemistry·2026
Same journal

DHRS2 as a Novel Thalidomide Target Regulating Mitophagy and Inflammation in Head and Neck Squamous Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

Synthetic AtMP2 from Anabas testudineus: Comprehensive ADMET and In Vivo Toxicity Assessment to Enable Future Therapeutic Development.

Current medicinal chemistry·2026
Same journal

Screening of Medicinal and Edible Homology Substances for Diabetic Kidney Disease Based on GraphBAN.

Current medicinal chemistry·2026
See all related articles

DNA secondary structures like hairpins are found in genomic DNA, particularly in gene regulatory regions. These structures may be targeted by drugs to control transcription factor binding and gene expression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • DNA secondary structures, including single-stranded regions, exist in prokaryotic and eukaryotic genomes.
  • These structures are frequently located in transcriptional regulatory elements like promoters.

Purpose of the Study:

  • To review the evidence for DNA secondary structures in genomic DNA.
  • To discuss the development of small molecules that bind these structures for therapeutic purposes.

Main Methods:

  • Literature review of studies on DNA secondary structures (hairpins, cruciforms).
  • Examination of identified hairpin- or cruciform-binding proteins.
  • Analysis of small molecule development targeting these DNA structures.

Main Results:

Related Experiment Videos

  • DNA secondary structures, such as hairpins and cruciforms, are present in genomic DNA, often in regulatory regions.
  • These structures can serve as recognition sites for transcription factors.
  • Specific examples, like the N4 virion RNA polymerase promoter hairpin, demonstrate functional relevance.

Conclusions:

  • Regulatory DNA secondary structures are implicated in gene transcription regulation.
  • These structures represent potential targets for novel therapeutic agents designed to modulate protein binding and gene expression.